A novel opioid structure which accepts protonated as well as non-protonated nitrogen: A family of pure, delta receptor selective antagonists

A. Rónai, J. Botyánszki, J. Hepp, K. Medzihradszky

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Conventional opioids including opioid peptides require an "opioid" nitrogen which exists in protonated state while interacting with the receptor. In the present paper we demonstrate that Tyr-Pro-Gly-Phe-Leu-Thr hexapeptide sequence accepts N-terminal substituents such as N-t-Boc, N-phenylacetyl and N-diphenylacetyl where the N cannot become protonated, as well as "traditional" substitutions such as N,N-diallyl, where protonation is likely under physiological conditions. The opioid peptides bearing these substituents are pure antagonists of medium affinity (Ke values in the mouse vas deferens bioassay against [Met5]-enkephalin are in the 3×10-7 - 4×10-6M range) with a high delta receptor preference (50 - 350-fold delta over mu selectivity ratios).

Original languageEnglish
Pages (from-to)1371-1378
Number of pages8
JournalLife Sciences
Volume50
Issue number18
DOIs
Publication statusPublished - 1992

Fingerprint

delta Opioid Receptor
Opioid Peptides
Opioid Analgesics
Bearings (structural)
Nitrogen
Vas Deferens
Bioassay
Enkephalins
Protonation
Biological Assay
Substitution reactions

ASJC Scopus subject areas

  • Pharmacology

Cite this

A novel opioid structure which accepts protonated as well as non-protonated nitrogen : A family of pure, delta receptor selective antagonists. / Rónai, A.; Botyánszki, J.; Hepp, J.; Medzihradszky, K.

In: Life Sciences, Vol. 50, No. 18, 1992, p. 1371-1378.

Research output: Contribution to journalArticle

@article{7afd2734a5de47b6b4666c3a6a199756,
title = "A novel opioid structure which accepts protonated as well as non-protonated nitrogen: A family of pure, delta receptor selective antagonists",
abstract = "Conventional opioids including opioid peptides require an {"}opioid{"} nitrogen which exists in protonated state while interacting with the receptor. In the present paper we demonstrate that Tyr-Pro-Gly-Phe-Leu-Thr hexapeptide sequence accepts N-terminal substituents such as N-t-Boc, N-phenylacetyl and N-diphenylacetyl where the N cannot become protonated, as well as {"}traditional{"} substitutions such as N,N-diallyl, where protonation is likely under physiological conditions. The opioid peptides bearing these substituents are pure antagonists of medium affinity (Ke values in the mouse vas deferens bioassay against [Met5]-enkephalin are in the 3×10-7 - 4×10-6M range) with a high delta receptor preference (50 - 350-fold delta over mu selectivity ratios).",
author = "A. R{\'o}nai and J. Boty{\'a}nszki and J. Hepp and K. Medzihradszky",
year = "1992",
doi = "10.1016/0024-3205(92)90288-Z",
language = "English",
volume = "50",
pages = "1371--1378",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "18",

}

TY - JOUR

T1 - A novel opioid structure which accepts protonated as well as non-protonated nitrogen

T2 - A family of pure, delta receptor selective antagonists

AU - Rónai, A.

AU - Botyánszki, J.

AU - Hepp, J.

AU - Medzihradszky, K.

PY - 1992

Y1 - 1992

N2 - Conventional opioids including opioid peptides require an "opioid" nitrogen which exists in protonated state while interacting with the receptor. In the present paper we demonstrate that Tyr-Pro-Gly-Phe-Leu-Thr hexapeptide sequence accepts N-terminal substituents such as N-t-Boc, N-phenylacetyl and N-diphenylacetyl where the N cannot become protonated, as well as "traditional" substitutions such as N,N-diallyl, where protonation is likely under physiological conditions. The opioid peptides bearing these substituents are pure antagonists of medium affinity (Ke values in the mouse vas deferens bioassay against [Met5]-enkephalin are in the 3×10-7 - 4×10-6M range) with a high delta receptor preference (50 - 350-fold delta over mu selectivity ratios).

AB - Conventional opioids including opioid peptides require an "opioid" nitrogen which exists in protonated state while interacting with the receptor. In the present paper we demonstrate that Tyr-Pro-Gly-Phe-Leu-Thr hexapeptide sequence accepts N-terminal substituents such as N-t-Boc, N-phenylacetyl and N-diphenylacetyl where the N cannot become protonated, as well as "traditional" substitutions such as N,N-diallyl, where protonation is likely under physiological conditions. The opioid peptides bearing these substituents are pure antagonists of medium affinity (Ke values in the mouse vas deferens bioassay against [Met5]-enkephalin are in the 3×10-7 - 4×10-6M range) with a high delta receptor preference (50 - 350-fold delta over mu selectivity ratios).

UR - http://www.scopus.com/inward/record.url?scp=0026511420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026511420&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(92)90288-Z

DO - 10.1016/0024-3205(92)90288-Z

M3 - Article

C2 - 1313941

AN - SCOPUS:0026511420

VL - 50

SP - 1371

EP - 1378

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 18

ER -